FDA 483 - Zhejiang Ludao Technology Co., Ltd. - August 14, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Zhejiang Ludao Technology Co. Ltd. in Taizhou, China, a finished drug manufacturer, was cited for significant data integrity and quality control deficiencies during an FDA inspection. Observations included unreliable laboratory records, uncontrolled documents, inadequate stability testing methods, deletion of analytical data, and untrained personnel. The firm also failed to follow change control procedures for formulation changes and had poor warehouse maintenance and insufficient API identity testing.
ID · 0ac0d970-3755-4e95-8882-51e5d3826043